Skip to main navigation

Utility Menu

  • Patients
  • Investors
  • Newsroom
  • Contact Us

Regional Navigation

  • global sites
    Global Sites
    • Switzerland flag
      Switzerland
      • Deutsch
      • English
      • Français
      • Italiano
    • UK flag
      UK
      • English
    • global sites
      United States
      • English

Utility Menu

  • Patients
  • Investors
  • Newsroom
  • Contact Us

Regional Navigation

  • global sites
    Global Sites
    • Switzerland flag
      Switzerland
      • Deutsch
      • English
      • Français
      • Italiano
    • UK flag
      UK
      • English
    • global sites
      United States
      • English
Home

Social Links

  • Twitter
  • LinkedIn
  • Instagram
  • Facebook

Main navigation

  • Our Disease Areas
    • Duchenne Muscular Dystrophy
    • Limb-girdle Muscular Dystrophy
  • Our Science
    • RNA Platform
    • Gene Therapy
    • Manufacturing
    • Strategic Partnerships
    • Investigator-Initiated Studies
  • Our Products & Pipeline
    • Products
    • Pipeline
    • Clinical Trials
    • Treatment Access
  • About Us
    • Leadership
    • Patient Affairs
    • Corporate Responsibility
    • Grants & Giving
    • Global Locations
    • Contact Us
  • Join Us
    • Career Opportunities

  • Home
  • Investor Relations
  • Earnings Conference Call

IR Menu

IR Home
Press Releases
Events & Presentations
Corporate Governance
Stock Information
SEC Filings
Analyst Coverage
Information Request
FAQs

Sarepta Therapeutics Fourth Quarter 2025 Earnings Call

  • Read more about Sarepta Therapeutics Fourth Quarter 2025 Earnings Call

Sarepta Therapeutics Third Quarter 2025 Earnings Call

  • Read more about Sarepta Therapeutics Third Quarter 2025 Earnings Call

Sarepta Therapeutics First Quarter 2025 Earnings Call

  • Read more about Sarepta Therapeutics First Quarter 2025 Earnings Call

Sarepta Therapeutics Fourth Quarter and Full-Year 2024 Earnings Call

  • Read more about Sarepta Therapeutics Fourth Quarter and Full-Year 2024 Earnings Call

Sarepta Therapeutics Third Quarter 2024 Earnings Call

  • Read more about Sarepta Therapeutics Third Quarter 2024 Earnings Call

Sarepta Therapeutics Second Quarter 2024 Earnings Call

  • Read more about Sarepta Therapeutics Second Quarter 2024 Earnings Call

Sarepta Therapeutics First Quarter 2024 Earnings Call

  • Read more about Sarepta Therapeutics First Quarter 2024 Earnings Call

Sarepta Therapeutics Fourth Quarter 2023 Earnings Call

  • Read more about Sarepta Therapeutics Fourth Quarter 2023 Earnings Call

Sarepta Therapeutics Third Quarter 2023 Earnings Call

  • Read more about Sarepta Therapeutics Third Quarter 2023 Earnings Call

Sarepta Therapeutics Second Quarter 2023 Earnings Call

  • Read more about Sarepta Therapeutics Second Quarter 2023 Earnings Call

Pagination

  • Page 1
  • Next page ››
Subscribe to Earnings Conference Call

Toolkit

Print Page | Email Alerts | RSS Feeds | Contacts

Follow Us On Social

  • Twitter
  • LinkedIn
  • Instagram
  • Facebook

Main navigation

  • Our Disease Areas
    • Duchenne Muscular Dystrophy
    • Limb-girdle Muscular Dystrophy
  • Our Science
    • RNA Platform
    • Gene Therapy
    • Manufacturing
    • Strategic Partnerships
    • Investigator-Initiated Studies
  • Our Products & Pipeline
    • Products
    • Pipeline
    • Clinical Trials
    • Treatment Access
  • About Us
    • Leadership
    • Patient Affairs
    • Corporate Responsibility
    • Grants & Giving
    • Global Locations
    • Contact Us
  • Join Us
    • Career Opportunities

©2026 Sarepta Therapeutics, Inc. All rights reserved.

Footer Utility Nav

  • Privacy Policy
  • Terms of Use
  • Data Privacy Framework Policy